Hjem › B-celle leukæmi › Texas › Dallas
B-celle leukæmi kliniske forsøg i Dallas, TX
5 studier for B-celle leukæmi søger deltagere på steder i og omkring Dallas (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
RekruttererFase 2
- UT Southwestern-Harold C. Simmons Cancer Center ( Site 2730), Dallas
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
RekruttererFase 2
- University of Texas, Southwestern, Dallas
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
RekruttererFase 1
- UT Southwestern Medical Center, Dallas
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
RekruttererFase 1/2
- University of Texas(UT) Southwestern-Children's Medical Center, Dallas
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
RekruttererObservationsstudie
- Ut Southwestern, Dallas
B-celle leukæmi forsøg i andre byer
- Houston, TX7 studier
- Washington, DC5 studier
- Columbus, OH4 studier
- Portland, OR4 studier
- Philadelphia, PA3 studier
- Spokane, WA3 studier
- New York City, NY3 studier
- Boston, MA3 studier
- Clifton, NJ3 studier
- San Diego, CA3 studier
- Charlotte, NC3 studier
- Louisville, KY3 studier
Andre studier i Dallas
- Brystkræft55 studier
- Ikke-småcellet lungecancer52 studier
- Metastatisk cancer42 studier
- Hjertesvigt42 studier
- Kræft (alle typer)37 studier
- Prostatakræft36 studier
- Colorektal kræft33 studier
- Overvægt30 studier
- Ægstockræft28 studier
- Blærecancer27 studier
- Lungecancer27 studier
- Livmoderslimhindekræft24 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.